![Foundation Medicine's Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers | Business Wire Foundation Medicine's Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers | Business Wire](https://mms.businesswire.com/media/20160418005213/en/519518/5/AACRPedsHandout.jpg)
Foundation Medicine's Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers | Business Wire
![1265714091 NPI Number | FOUNDATION MEDICINE, INC. | CAMBRIDGE, MA | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023 1265714091 NPI Number | FOUNDATION MEDICINE, INC. | CAMBRIDGE, MA | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023](https://www.hipaaspace.com/medical_billing/coding/national_provider_identifier/codes/npi_1265714091.png)
1265714091 NPI Number | FOUNDATION MEDICINE, INC. | CAMBRIDGE, MA | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023
![Buy Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Components) Book Online at Low Prices in India | Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Buy Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Components) Book Online at Low Prices in India | Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite](https://m.media-amazon.com/images/I/61ttR2hOjgL._AC_UF1000,1000_QL80_.jpg)
Buy Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite Components) Book Online at Low Prices in India | Price-Forecasting Models for Foundation Medicine, Inc. FMI Stock: 1372 (NASDAQ Composite
![Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care Foundation Medicine Acquires Lexent Bio, Inc., to Accelerate Liquid Biopsy Research and Development, and Advance Cancer Care](https://www.hhmglobal.com/wp-content/uploads/news/24584/Foundation_Medicine_Acquires_Lexent.jpg)